iCASE students apply for a specific project which has been designed by two supervisors - one from Warwick and one from an industry partner. They spend a minimum of three months based with their industry partner.
Projects available for September 2020 entry:
Project title: Modifying macrophage phenotype as a potential treatment for endometriosis
Warwick supervisors: Dr Erin Greaves, Dr Andrew Blanks and Prof. Sebastien Perrier
Industry supervisor: Dr Greg Ferguson (Ferring Pharmaceuticals, San Diego)
Endometriosis (ectopic growth of endometrial-like tissue) is a chronic inflammatory disorder associated with pelvic pain and infertility. Current treatments are limited and associated with side-effects and recurrence. New therapies are desperately needed. Immune cells called macrophages are central to the pathophysiology of endometriosis. The local disease environment modifies macrophages such that they promote growth, vascularization and innervation of lesions. The Greaves lab. is seeking a highly motivated PhD candidate to explore the modification of macrophage phenotype using targeted drug delivery. This is a collaboration between Warwick Medical School, the Department of Chemistry and Ferring Pharmaceuticals and offers a 3-month placement in San Diego, California, at Ferring headquarters.
Applicants should have a strong undergraduate degree in biomedical sciences (or similar) and interests in immunology and polymer chemistry / materials science.